8
Biomarker Conference February 18 - 19, 2016 San Diego - CA, USA Biomarker Conference Discovery | Validation | Clinical | Application | Regulations February 18 - 19, 2016 M NM CONFERENCES San Diego, USA Post Show 2016 Event Supported by: Four Points by Sheraton, San Diego - CA, USA This event was co-located with Genome Editing & Engineering Conference & NGS Data Analysis and Informatics Conference

Biomarker Biomarker Conference Conference - Life … show_28 june.pdf · Dr. Srivastava’s presentation on cancer Biomarker validation for clinical ... Beyond PD-L1 presented by

Embed Size (px)

Citation preview

Page 1: Biomarker Biomarker Conference Conference - Life … show_28 june.pdf · Dr. Srivastava’s presentation on cancer Biomarker validation for clinical ... Beyond PD-L1 presented by

Biomarker ConferenceFebruary 18 -19, 2016 San Diego-CA, USA

BiomarkerConferenceDiscovery | Validation | Clinical | Application | Regulations

February 18 -19, 2016

MnM COnFEREnCES

San Diego, USA

Post Show 2016Post Show 2015

Event Supported by:

Four Points by Sheraton, San Diego-CA, USA

This event was co-located with Genome Editing & Engineering Conference & NGS Data Analysis and Informatics Conference

Page 2: Biomarker Biomarker Conference Conference - Life … show_28 june.pdf · Dr. Srivastava’s presentation on cancer Biomarker validation for clinical ... Beyond PD-L1 presented by

Biomarker ConferenceFebruary 18 -19, 2016 San Diego-CA, USA

Event Overview

The Biomarker Conference that took place on the 18th and 19th of Feb, 2016 at the Four Points by Sheraton hotel in San Diego, CA was a huge success and welcomed more than 120 attendees from pharma, biopharma and biotech companies.The stimulating business-focused atmosphere was clearly felt by all during the 2-day event which was co-located with the NGS Data Analysis and Informatics and Genome Editing and Engineering ConferenceRecent breakthroughs in biomarker discovery, validation and regulatory guidelines were presented in the form of case studies in consort with some of the evolving cost-effective technologies.The co-located event included ample networking time and gave an opportunity and a platform to discuss and interact with attendees from all the three meetings.This post-show report summarises the 2016 event to demonstrate how the conference has grownand plans to deliver and expand the event for the future. If you are already involved with us as an exhibitor, visitor or delegate, we would like to thank you for your continued support in making it such a great success.

Key Highlights

Dr. Srivastava’s presentation on cancer Biomarker validation for clinical application was one of the most remarkable and expedient presentation where he spoke about different validation strategies.

Biomarkers for Cancer Immunotherapy: Beyond PD-L1 presented by Dr. Sandip Patel, Assistant Professor, Cancer Immunotherapy Program from the UC San Diego Moores cancer Centre gained a huge response and was the most talked about presentation.

Dr. Baolin Zhang and Dr. Abraham Tzou from FDA (CDER/OPQ/OBP and CDRH respectively) delivered the most significant topics regarding predictive biomarkers for targeted cancer therapies: the roadmap to personalized medicine and regulatory aspects for prognostic and CDx.

Dr. Michael Heller, professor, Departments of Bioengineering and nano Engineering, UCSD presented another exciting topic; Rapid detection and analysis of DNA/RNA/Exosome Biomarkers were he discussed the technologies used and detection strategies.

Day 2 of the conference was chaired by Dr. Jurgen Scheuenpflug, Global head Clinical Biomarkers from Merck KGaA had some of the key industry experts from top pharma companies discussing on clinical biomarkers.

Key Highlights

Page 3: Biomarker Biomarker Conference Conference - Life … show_28 june.pdf · Dr. Srivastava’s presentation on cancer Biomarker validation for clinical ... Beyond PD-L1 presented by

Biomarker ConferenceFebruary 18 -19, 2016 San Diego-CA, USAOur Partners 2016

Page 4: Biomarker Biomarker Conference Conference - Life … show_28 june.pdf · Dr. Srivastava’s presentation on cancer Biomarker validation for clinical ... Beyond PD-L1 presented by

Biomarker ConferenceFebruary 18 -19, 2016 San Diego-CA, USA

CEO’s, CSO’s, VP’s, Directors:

20%

Scientist, Researchers,

Heads, Managers: 50%

Professors, PHD Students, Research Fellows:

30%

ATTENDEE BREAKDOWNJOB TITLE WISE

USA: 91%

UK/Europe:5% Rest of the

World2%

Asia:2%

ATTENDEE BREAKDOWNJOB TITLE WISE

Page 5: Biomarker Biomarker Conference Conference - Life … show_28 june.pdf · Dr. Srivastava’s presentation on cancer Biomarker validation for clinical ... Beyond PD-L1 presented by

Biomarker ConferenceFebruary 18 -19, 2016 San Diego-CA, USA

Attendee 2016

• McGill University Health Centre• Abbvie Inc• Abcam• Ablynx, Belgium• Agilent Technologies• Agios Pharmaceuticals Inc• Akamai Strategies• Aldevron• ALLICE• Ambrose Alli University• Angle Plc• Archer Dx Inc• Arima Genomics• Asterand Bioscience• Astrazeneca• Audentes Therapeutics, Inc• Benaroya Research Institute• Bina Roche• Bina Technologies / Roche• BioAgilytix Labs• Biogen• Biovica International AB• Bristol-Myers Squibb• Broad Institute• Cal State University Chico• California State University• California State University, Fullerton• Cancer Genetics, Inc• Canik Basari University – TURKEY• Cedars-Sinai• Cedars-Sinai Medical Center• Celerion• Cellectis• Center for Scientific Research and Higher

Education of Ensenada (CICESE)• Centogene AG• Chaitanya College Pharmacy Education• Chinese Academy of Medical Sciences • Cibus• CICESE• CICESE Research Center• Cold Spring Harbor Labs• Complete Genomics Inc.• CSU, Chico• Daiichi Sankyo Pharma Development• Dana-Farber Cancer Institute• Dana-Farber Cancer Institute • Harvard School of Public Health• Date4Cure• Desktop Genetics• DNAnexus• DxTerity• Edico Genome• Eisai• Eisai Co., Ltd.• Eli Lilly• Emory University• ETAGEN Pharma• Excelra Knowledge Solutions Pvt. Ltd.• FAA• Fate Therapeutics• Fate Therapeutics, Inc.• FDA | CDER/OPQ/OBP• FDA/CDRH/OIR/DMGP• Feng Zang Lab• Ferring Research Institute• Genection-Invivoscribe• Genedata• Genome Profiling, LLC

• Genoptix• Georgia Institute of Technology• Gilead• Girihlet• GNF (Novartis)• Grifols• GSK• Guardiome• Guardiome, LLC• Halozyme• Harvard Medical School• Helen F. Graham Cancer Center• Henan Agricultural University• IBMS, Academia Sinica• IGM Genomics Facility• IGM Genomics Facility at UCSD• Illumina• Immunocept Medical Products, LLC• Indiana School of Medicine• Indivumed• Institute of Genetics and Molecular and Cellular

Biology (IGBMC)• Intertek Pharmaceutical Services• J. Craig Venter Institute• J. R. Simplot Company, Plant Sciences• Janssen Pharmaceuticals of Johnson and Johnson• Janssen Research & Development• Japan Bioindustry Association• John Wayne Cancer Institute• Johns Hopkins Medical Institutions• Johns Hopkins University • KCAS Bioanalytical & Biomarker Services• Keck Graduate Institute• Kyung Hee University• LEO Pharma• Lieber Institute/Johns Hopkins University• Lincoln Memorial University• Lonza Walkersville, Inc• Massachusetts General Hospital• Maverixbio• Mayo Clinic• MedGenome Labs Pvt.Ltd• Medical Discovery Institute• MedImmune• Merck• Merck KGaA• MicroConstants Inc• MilliporeSigma Company• MIT• Molecular Health• Moores Cancer Center• Moores Cancer Center, UCSD• Moores UC San Diego Cancer Center• National Cancer Institute• National Center for Toxicological Research, US FDA• National Human Genome Research Institute• Nevada Institute• New York Genome Center• NIST• Novartis• Nucelis Llc• Peking Union Medical College• Personal Genome Diagnostics• Pfizer• Pfizer Inc• Pharmanostics, Inc.• Prostagene• Regulus Therapeutics• Research Dx

• Roche Innovation Center New York• Rosalind Franklin University• Salk Institute for Biological Studies• San Diego State University• San Diego Supercomputer Center• Sanford Burnham Prebys• SBP Medical Discovery Institute• SCIEX• Second Genome• SeqHub Analytics• Seven Bridges• Spartan Bioscience• State University of New York Upstate • Stein Eye Institue UCLA• Sun Yat-Sen University• Syngenta• Synthetic Genomics, Inc.• Systems Biology Research Group• The Scripps Research Institute• The State University of New York at Buffalo• The Wistar Institute• Thermofisher• Tocagen Inc.• Trovagene• Tunghai University• UAEU• UC Davis• UC Irvine• UC San Diego Health Science• UC San Diego Moores Cancer Center• UCLA David Geffen School of Medicine• UCLA, River side• UCSD Moores Cancer Center Biorepository• UCSF• University at Buffalo• University of Alabama• University of British Columbia• University of California• University of California at Davis• University of California San Diego • Scripps Institution of Oceanography• University of California, Davis• University of California, Irvine• University of California, Riverside• University of California, San Diego• University of California, San Francisco• University of Colorado• University of Copenhagen• University of Florida• University of Miami• University of Minnesota• University of San Diego• University of Sao Paulo• University of Sevilla• University of Southern California• University of Texas Health Science Center at Houston• UNMC• UNRWA• UT Southwestern Medical Center• Vertex• Vertex Pharmaceuticals• Warsaw University of Life Science-SGGw• Weill Cornell Medical College, New York• Women’s Health Research Unit• Yale University• Yale University- School of Medicine• Yenos Analytical LLC• Ymir Genomics

Page 6: Biomarker Biomarker Conference Conference - Life … show_28 june.pdf · Dr. Srivastava’s presentation on cancer Biomarker validation for clinical ... Beyond PD-L1 presented by

Biomarker ConferenceFebruary 18 -19, 2016 San Diego-CA, USA

Dr. Afshin SafaviFounder & Chief Scientific OfficerBioagilytix Labs

Prof. Arndt RolfsChief Executive OfficerCENTOGENE AG

Adam MarshCo-founder and CSOGenpro LLC, Newark, USA

Daniel R. Salomon, M.D.Professor, Molecular and Experimental Medicine, Director, Laboratory for Functional Genomics, Program Medical Director, The Scripps Research Institute and Scripps Health, La Jolla, CA

Josh StahlVP of R&D and Scientific OperationsArcherDX, Boulder, USA

Theresa ZhangVice President, Research ServicesPersonal Genome Diagnostics, Boston, USA

Dr. Jürgen ScheuenpfiugGlobal Head Clinical Biomarkers & Companion Diagnostics Merck KGaA, Darmstadt, Germany

Dr. Michele MercuriSr. VP, Clinical Development, Head of Clinical, Development for the AmericasDaiichi Sankyo Inc., New Jersey, USA

Dr. Abraham Tzou Medical Officer, Center for Devices and Radiological Health FDA | CDRH, Maryland, USA

Dr. Stefan J. SchererVP Global Head Correlative ScienceNovartis Pharmaceuticals Corporation, New Jersey, USA

Dr. Amir Handzel Statistical Science Director Astrazeneca, Waltham MA, USA

Dr. Sittichoke SaisanitData Scientist, InformaticsRoche Innovation Center New York, USA

Dr. Baolin Zhang Senior Investigator & Product Quality ReviewerFDA | CDER/OPQ/OBP, Maryland, USA

Dr. Sudhir Srivastava Chief, Cancer Biomarkers NCI/NIH, Washington, USA

Dr. Suso Platero Sr. Director Translational Research Oncology Janssen Research & Development, Philadelphia, USA

Dr. Qihong Huang Associate professor in the Tumor Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, USA

Dr. Michael Heller Professor, Departments of Bioengineering and Nano Engineering, (ECE) UCSD, San Diego, USA

Dr. Darrell Borger Director, Biomarker Laboratory, Mass General Hospital Massachusetts General Hospital, Harvard Medical School, Boston, USA

Dr. Howard J FederoffVice Chancellor of Health Affairs & SOM DeanUCI

Dr. Quang-Dé Nguyen Director Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, USA

Dr. Sandip PatelAssistant Professor, Cancer Immunotherapy ProgramUC San Diego Moores Cancer Center, San Diego, USA

Dr. Jody BerryDirector, Immunochemistry, Research and Development, Diagnostic Industrial GroupGRIFOLS, California, USA

Rafiq IslamSenior Director, Bioanalytical ServicesCelerion Inc., USA

Dr. Kamala MaddaliVP, Biopharm Market Development, Collaborations and Companion Diagnostics, Cancer Genetics, New Jersey, USA

Dr. Paul L. WoodDirector, Professor, Physiology & Pharmacology, DeBusk College of Osteopathic Medicine, Tennessee, USA

Dr. Francie BarronVP Biology and Regulatory AffairsNanomedical Diagnostics, San Diego, USA

Dr. Jane HouldsworthVice-President-R&DCancer Genetics, Inc., New Jersey, USA

Confirmed Speakers:

Page 7: Biomarker Biomarker Conference Conference - Life … show_28 june.pdf · Dr. Srivastava’s presentation on cancer Biomarker validation for clinical ... Beyond PD-L1 presented by

Biomarker ConferenceFebruary 18 -19, 2016 San Diego-CA, USA

Testimonials

Sponsor Feedback:

Media Partners:

“ I am happy to have participated! The 2 days format was good, the quality and relevance of the talks were excellent, and the overall logistic and organization were top notch.”

-Director, Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, USA

“We met several important potential customers with whom we are deep into partnership discussions.”DxTerity

“ Positive outcome regarding networking possibilities. Interesting for CENTOGENE to get in contact with industry partners”

CENTOGENE

“I learned a lot from many great talks on the biomarker topic that I’m not all that familiar with. I think it was overal a great conference.”-Data Scientist, Informatics, Pharmaceutical Research and Early Development,

Roche Innovation Center New York, New York, USA

“I think it was a successful conference. I hope that your company will continue to host such events to make it an annual conference on biomarkers.”-Associate professor, Tumor Microenvironment and Metastasis Program,

The Wistar Institute, Philadelphia, USA

“Thank you for organising this successful and interesting conference.”-Statistical Science Director, Astrazeneca, Waltham MA, USA

Page 8: Biomarker Biomarker Conference Conference - Life … show_28 june.pdf · Dr. Srivastava’s presentation on cancer Biomarker validation for clinical ... Beyond PD-L1 presented by

Biomarker ConferenceFebruary 18 -19, 2016 San Diego-CA, USA

MarketsandMarkets Conferences (MnM Conferences) is a wholly owned division of MarketsandMarkets a global market research and intelligence company producing over 1200 premium market research reports every year across 12 different industry verticals. By bringing together expert speakers from across the world and leading technology and service providers, MnM Conferences provides a senior level educational and networking platform where knowledge is shared and partnerships and collaborations can be formed.

With offices in Asia and Europe, MnM Conferences ensures a truly global attendance at every event where attendees, speakers, exhibitors and sponsors can exchange ideas in a relaxed and professional environment.

About MnM Conferences:

Submitting Paper Proposal:You can submit your paper proposal on any of the event topics, which will be available on the events website shortly.Contact: Namrata Naikpawar | Conference ProducerE: [email protected] | T: +91 8806 931 519

Participating As A Delegate:You can always contribute by sharing your knowledge with your peers and colleagues.E: [email protected] | T: +91 9892 830 873

Exhibiting Or Sponsoring At The Event:

In 2016, the event will be expanding its exhibition area and will offer an opportunity for exhibiting and showcasing your latest technologies, services, and products. We offer tailor made packages to sponsor the event based on your marketing budget.Contact: Adityaraj Amin| Sponsorship ManagerE: [email protected] | T: +91 9892 830 873

Media Alliances

We actively collaborate with publications, online portals and not-for-profit associations. To know more write to us.Contact: Ajay Nimbalkar| Marketing ManagerE: [email protected] | T: +91 20 30108 270

How To Participate In Year 2017?

MnM COnFEREnCES

+91 20 30108 270 | +44 (0)[email protected] | www.mnmconferences.com

2nd Annual Biomarker Conference6 - 7 February 2017, San Diego-CA, USA

Meet us again at